GPP

Great Point Partners Portfolio holdings

AUM $240M
1-Year Est. Return 106.75%
This Quarter Est. Return
1 Year Est. Return
+106.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$85.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$15.2M
3
+$14.9M
4
APGE icon
Apogee Therapeutics
APGE
+$12.1M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$10.5M

Top Sells

1
+$96.9M
2
+$27.5M
3
+$7.71M
4
AKBA icon
Akebia Therapeutics
AKBA
+$7.23M
5
EOLS icon
Evolus
EOLS
+$6.63M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SANA icon
26
Sana Biotechnology
SANA
$1.37B
$2.48M 1.02%
+700,000
ABSI icon
27
Absci
ABSI
$547M
$2.42M 1%
+796,438
PLRX icon
28
Pliant Therapeutics
PLRX
$75.6M
$1.26M 0.52%
850,000
ACLX icon
29
Arcellx
ACLX
$4.16B
– –
-100,000
AKBA icon
30
Akebia Therapeutics
AKBA
$441M
– –
-1,985,915
CAPR icon
31
Capricor Therapeutics
CAPR
$1.42B
– –
0
CNTA
32
Centessa Pharmaceuticals
CNTA
$3.92B
– –
-225,000
EOLS icon
33
Evolus
EOLS
$456M
– –
-720,118
HRMY icon
34
Harmony Biosciences
HRMY
$2.33B
– –
0
KALV icon
35
KalVista Pharmaceuticals
KALV
$855M
– –
-323,170
PMN icon
36
ProMIS Neurosciences
PMN
$19.4M
– –
-2,645,128
SRRK icon
37
Scholar Rock
SRRK
$4.78B
– –
-61,607
BBOT
38
BridgeBio Oncology
BBOT
$1.01B
– –
-29,381
1
2